New Zealand markets closed

  • NZX 50

    11,580.81
    -14.13 (-0.12%)
     

  • NZD/USD

    0.6205
    -0.0049 (-0.78%)
     

  • NZD/EUR

    0.5760
    -0.0006 (-0.11%)
     

  • ALL ORDS

    7,137.60
    -11.00 (-0.15%)
     

  • ASX 200

    6,955.20
    -13.40 (-0.19%)
     

  • OIL

    69.20
    -0.76 (-1.09%)
     

  • GOLD

    1,981.00
    -14.90 (-0.75%)
     

  • NASDAQ

    12,767.05
    +37.82 (+0.30%)
     

  • FTSE

    7,405.45
    -94.15 (-1.26%)
     

  • Dow Jones

    32,237.53
    +132.28 (+0.41%)
     

  • DAX

    14,957.23
    -253.16 (-1.66%)
     

  • Hang Seng

    19,915.68
    -133.96 (-0.67%)
     

  • NIKKEI 225

    27,385.25
    -34.36 (-0.13%)
     

  • NZD/JPY

    81.0810
    -0.6720 (-0.82%)
     

Karuna Therapeutics to Present at the SVB Securities Global Biopharma Conference

Business Wire
·1-min read

BOSTON, February 09, 2023--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that management will present at the SVB Securities Global Biopharma Conference on Tuesday, February 14, 2023, at 2:20 p.m. EST.

A live webcast of the presentation will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcast will also be archived for up to 30 days on Karuna’s website following the conference.

About Karuna
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005220/en/

Contacts

Investors:
Alexis Smith
518-338-8990
asmith@karunatx.com

Media:
Bob Josefsberg
646-734-3584
bjosefsberg@karunatx.com

Latest stories